Tag Archives: vaccine

Blog

Bio Farma’s Bio-TCV typhoid conjugate vaccine licensed in Indonesia following marketing approval

Posted on by info
Bio Farma’s Bio-TCV typhoid conjugate vaccine licensed in Indonesia following marketing approval
09
Nov

The International Vaccine Institute (IVI), a world organization with a mission to find, develop, and deliver secure, effective, and reasonably priced vaccines for global health, and Bio Farma, a biotechnology company based in West Java, Indonesia, announced today that Bio Farma’s Bio-TCV® typhoid conjugate vaccine (TCV) was licensed in Indonesia following marketing approval from Badan […]

Continue reading →
Blog

What were the explanations for COVID-19 vaccine refusal in Hong Kong?

Posted on by info
What were the explanations for COVID-19 vaccine refusal in Hong Kong?
23
Oct

In a recent study published in JAMA Network Open, researchers examined the willingness to simply accept the coronavirus disease 2019 (COVID-19) vaccine and reasons for hesitancy in Hong Kong. Study: COVID-19 Vaccination Willingness and Reasons for Vaccine Refusal. Image Credit: Anishka Rozhkova/Shutterstock.com Background Hong Kong has been exemplary in its response to the COVID-19 pandemic until the […]

Continue reading →
Blog

Promising breakthroughs ignite hope for a novel and effective Tuberculosis vaccine

Posted on by info
Promising breakthroughs ignite hope for a novel and effective Tuberculosis vaccine
17
Oct

A recent Npj Vaccines study discussed the success and challenges of developing different tuberculosis (TB) vaccine types. Study: Key advances in vaccine development for tuberculosis—success and challenges. Image Credit: Creativa Images/Shutterstock.com Effectiveness of BCG vaccine against TB In 1982, Robert Koch first identified the TB-causing bacterial pathogen Mycobacterium tuberculosis. TB treatment is expensive and lengthy and will require 6-9 months […]

Continue reading →
Blog

Gates Foundation publicizes investments to advance mRNA vaccine research and manufacturing

Posted on by info
Gates Foundation publicizes investments to advance mRNA vaccine research and manufacturing
15
Oct

On the 2023 Grand Challenges Annual Meeting, Bill Gates, Co-chair of the Bill & Melinda Gates Foundation, announced latest investments to advance access to mRNA research and vaccine manufacturing technology that can support low- and middle-income countries’ (LMICs) capability to develop high-quality, lifesaving vaccines at scale. Image Credit: Univercells The move builds on lessons the […]

Continue reading →
Blog

Pfizer Australia and BioNTech announce TGA approval for Omicron XBB.1.5-adapted monovalent COVID-19 vaccine

Posted on by info
Bio Farma’s Bio-TCV typhoid conjugate vaccine licensed in Indonesia following marketing approval
14
Oct

Pfizer Australia and BioNTech SE today announced that the Therapeutic Goods Administration (TGA) have authorized the businesses’ XBB.1.5-adapted monovalent COVID-19 vaccine (COMIRNATY® Omicron XBB.1.5) in individuals 5 years and older. Omicron XBB sublineages account for the vast majority of COVID-19 cases globally2. Although Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccines provide some protection against a variety of […]

Continue reading →
Blog

Moderna’s updated COVID-19 vaccine for Autumn 2023 outperforms in cost and clinical impact

Posted on by info
Moderna’s updated COVID-19 vaccine for Autumn 2023 outperforms in cost and clinical impact
13
Oct

In a recent study posted to medRxiv preprint* server, researchers at pharmaceutical and biotechnology company Moderna, Inc. estimated the economic and clinical impact of updated messenger ribonucleic acid (mRNA) vaccines for coronavirus disease 2019 (COVID-19). Study: Clinical impact and cost-effectiveness of the updated COVID-19 mRNA Autumn 2023 vaccines in Germany. Image Credit: etraveler / Shutterstock *Essential notice: […]

Continue reading →
Blog

A novel multi-epitope vaccine targeting extracellular proteins of Chlamydia pneumoniae

Posted on by info
A novel multi-epitope vaccine targeting extracellular proteins of Chlamydia pneumoniae
14
Sep

In a recent study published in Scientific Reports, a bunch of researchers designed and evaluated a multi-epitope vaccine targeting the principal outer membrane protein (MOMP) protein of Chlamydia pneumoniae (C. pneumoniae; Cpn) using immunoinformatics. They assessed the vaccine’s interaction with immune receptors and expressed it in silico on a baculovirus vector for potential protection against […]

Continue reading →
Blog

Early viral exposure in mice weakens vaccine response, raising questions for human studies

Posted on by info
Early viral exposure in mice weakens vaccine response, raising questions for human studies
06
Sep

In a preprint* research paper recently uploaded to the bioRxiv server, researchers at Washington University investigated how the exposome can mediate immune function in house mice, probably the most widely used model systems for in vivo immunological experimentation. Mice were sequentially inoculated with six different viral pathogens from formative years (neonatal) stages, following which their […]

Continue reading →
Blog

Scientists leverage machine learning and AI to guide vaccine development

Posted on by info
Bio Farma’s Bio-TCV typhoid conjugate vaccine licensed in Indonesia following marketing approval
12
Aug

From tackling homework challenges to drafting emails, persons are discovering an enormous array of applications for natural language processing tools like generative artificial intelligence (AI) engines. Now, researchers from Pacific Northwest National Laboratory (PNNL) and Harvard Medical School (HMS) are using this same form of technology to construct a knowledge base to be able to […]

Continue reading →
Blog

Novel vaccine against Lyme disease reported to be secure and effective

Posted on by info
Novel vaccine against Lyme disease reported to be secure and effective
11
Jul

In a recent study published in The Lancet Infectious Diseases, researchers determine the security and immunogenicity of a novel candidate vaccine against Lyme borreliosis. Study: Safety and immunogenicity of a novel multivalent OspA-based vaccine candidate against Lyme borreliosis: a randomised, phase 1 study in healthy adults. Image Credit: Evgeniyqw / Shutterstock.com What’s Lyme disease? Lyme borreliosis is a tick-borne […]

Continue reading →